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Smooth muscle cells improve endothelial cell
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Objective: We investigated the influence of smooth muscle cells (SMC) on endothelial cell (EC) retention on polytetra-
fluoroethylene (PTFE) grafts and the effect of SMC seeding on intimal hyperplasia in vivo in a rabbit model.
Methods: Fibronectin-coated PTFE grafts (4 mm diameter) were seeded with either EC alone, SMC alone, or SMC
followed 24 hours later by EC. The grafts were connected to an extracorporal aortic shunt for 1 hour or were individually
implanted for 1, 30, and 100 days into the infrarenal aorta as an end-to-side bypass graft. The number of retained cells
was compared at 1 hour and at 1 day after implantation. Neointimal thickness was measured 30 and 100 days after
implantation.
Results: After 1-hour exposure to blood flow, EC retention rate was greater (P < .005) if seeded on top of SMC (98% 
2%; n  8) versus being seeded alone (65  11%; n  8). SMC retention rate was 95  5% (n  8) when seeded alone.
Similar cell retention was obtained 1 day after implantation. After 30-day implantation the neointima was thicker in
grafts seeded with EC and SMC (282  136 m; n  3) than with EC only (52  45 m; n  3; P < .001). However,
the neointimal thickness for dual-cell–seeded grafts (126  60 m; n  3) was not significantly different (P  .09) from
EC-seeded grafts (79  48 m; n  3) after 100-day implantation.
Conclusion: EC retention on PTFE grafts in vivo is improved if seeded over a layer of SMC. Further studies are needed to
determine whether overlying EC modulate proliferation of underlying SMC. (J Vasc Surg 2003;38:557-63.)
Seeding a polytetrafluoroethylene (PTFE) graft lumi-
nal surface with endothelial cells (EC) has been advocated
to reduce surface thrombogenicity and improve patency.1,2
Although improved patency has been reported in animal
models,3,4 studies in human beings have yielded mixed
results. Deutsch et al5 reported a 9-year patency rate of 65%
for EC-seeded PTFE grafts, versus 16% for the unseeded
control group. On the other hand, Jensen et al6 reported
that long-term outcome is not obviously influenced by EC
seeding. One obstacle is that EC adhere poorly to PTFE
and are easily stripped off when exposed to blood flow.
Extracellular matrix (ECM), eg, fibronectin, collagens,
and proteoglycans, secreted from cells functions as a phys-
ical scaffold for cell attachment and serves as a local signal
transducer of SMC function. Cell attachment results from
the interaction between the cell surface receptors, inte-
grins,7 and ECM. Precoating ECM on the surface of PTFE
grafts benefits seeded cell adhesion.8,9 Myofibroblasts and
SMC secrete a greater amount of ECM than EC do.
Seeding of SMC on grafts has been studied by a few
groups,10,11 but not in the context of enhancing EC seed-
ing and retention and the effect on intimal thickness.
Retention of seeded cells on grafts has been studied
both in vitro and in vivo. Laminar flow studies with a
variable width flow chamber were performed to determine
the effect of biochemical treatment of graft surface on
enhancing EC adhesion.12 A nonpulsatile in vitro flow
circuit with a constant pressure was used to study cell
retention,13,14 and a pulsatile in vitro flow system was used
in our previous study of cell retention.15 Using this in vitro
flow system, we demonstrated that a SMC cellular layer
between seeded EC and the graft surface can be used to
enhance EC retention on prosthetic grafts.
In vivo studies of cell retention on prosthetic grafts
were conducted by implanting seeded grafts into dogs for 1
hour16 or 5 hours17 or into sheep for 2 hours.14 Arterio-
venous femoral shunts connecting a PTFE graft seeded
with EC that were virally engineered to express tissue
plasminogen activator (tPA) were placed in a baboon for 1
hour to study antithrombotic effects of seeded cells.18
These large animal studies are costly and labor intensive.
We report a simpler way to determine whether EC reten-
tion is improved in vivo by SMC seeding in a rabbit model.
MATERIAL AND METHODS
Isolation of EC and SMC. The experimental proto-
col was approved by the University of Southern California
Animal Care and Use Committee. EC and SMC were
isolated from the jugular vein of a rabbit. New Zealand
White rabbits weighing approximately 4 kg were anesthe-
tized with intramuscular injection of ketamine (40 mg/kg)
and xylazine (10 mg/kg). The jugular vein was exposed,
ligated, excised, placed in transport solution, and trans-
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ported from the operating room to the laboratory in RPMI
1640 medium (Gibco BRL, Gaithersburg, Md) containing
20 mmol/L of HEPES (N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid), 2 mmol/L of L-glutamine, 50 U/mL of
penicillin, 50 g/mL of streptomycin, 2.5 g/mL of genta-
micin, and 2.5 g/mL of amphotericin B. The veins were
flushed with RPMI medium, clamped at one end, filled
with 0.1% collagenase I (Gibco BRL) in Dulbecco phos-
phate-buffered saline solution (DPBS), and incubated for
10 minutes at 37° C. The dissociated EC were pelleted with
centrifugation at room temperature, at 1200 rpm (200g)
for 5 minutes. Cells were resuspended and plated onto 0.1%
fibronectin precoated dishes with EC medium containing
MCDB 131 medium (Gibco BRL), 20% fetal bovine serum
(FBS) (Hyclone, Logan, Ut), 50 g/mL of porcine intes-
tinal mucosa-derived heparin (Sigma, St Louis, Mo), 50
g/mL of EC growth supplement (Becton Dickinson,
Franklin Lakes, NJ), 2 mmol/L of L-glutamine (Gibco
BRL), and the antibiotics (penicillin, streptomycin, genta-
micin, amphotericin B).
After EC dissociation, the SMC were harvested as
follows. The vein was incised longitudinally, and the inti-
mal layer was scraped off with a scalpel. The opened vein
was incubated with DPBS containing collagenase I (1.8
mg/mL), and elastase (0.2 mg/mL), for 1 hour at 37° C.
The single-cell suspension supernatant was removed and
pelleted with centrifugation at 1200 rpm for 5 minutes.
The SMC were resuspended and cultured in Williams me-
dium (Gibco BRL) containing 20% FBS, L-glutamine (2
mmol/L), and the same antibiotics. EC were characterized
by cellular architecture under phase contrast microscopy,
and by fluorescent staining for von Willebrand factor and
low-density lipoprotein uptake. SMC were identified by the
presence of cytoplasmic smooth muscle -actin. All cells
were maintained in a humidified 37° C incubator with 5%
carbon dioxide, and were passaged at a 1:5 ratio and used
for experiments between passages 2 through 10.
Retroviral production and cell transduction. The
replication-incompetent murine leukemia virus (MuLV)–
derived viral vectors were pseudotyped with vesicular sto-
matitis virus G glycoprotein (VSV-G) envelope. The vec-
tors were generated from producer cell lines 293/GPG/X,
where X represents the vectors G1nBgSvNa and LGFPSN,
as described.15 The viral titers were between 106 and 107
colony formation units (cfu) per milliliter, analyzed with
neomycin resistance assay. All gene transfers were mediated
with the VSV-G pseudotyped MuLV (VSV-G/MuLV)
vectors generated from the producer cell lines
293/GPG/X.
Transduction of EC and SMC with viral vectors was as
described,19 by overlaying viral supernatants containing 8
g/mL of polybrene on cells plated on culture dishes for 2
hours, followed by G418 (Gibco BRL) selection.
Cell seeding. Expanded PTFE grafts (thin wall; inter-
nal diameter, 4 mm) were provided by IMPRA (Tempe,
Ariz) and seeded with cells as described.15 In brief, the
grafts were coated with fibronectin (0.1 mg/mL in PBS;
Gibco BRL) by squeezing the solution through the graft
wall, then filled with cell suspension (3  105 cells/mL),
heat-crimped at both ends, and rotated at 1 rpm for 2 hours
at 37° C. After the cell suspension was removed, the grafts
were cultured in a culture dish with medium for 1 day
before being tested in blood flow. For 1-hour flow experi-
ments, heterogenic cells were used; for 1-day, 30-day, and
100-day implantation, autologous cells were used.
For single cell seeding, both EC and SMC were trans-
duced with retroviral vectors carrying the lacZ gene. The
grafts were stained with X-gal to visualize the seeded
cells,20 and cell numbers were counted under a microscope.
For dual-layer seeding, EC were transduced with the lacZ
gene, and SMC were transduced with the gene coding for
GFP. EC and SMC were readily distinguishable at X-gal
staining and fluorescence microscopy. SMC were seeded on
PTFE grafts coated with fibronectin, as described above.
The grafts were cultured for 1 day before EC were seeded
over SMC.
In vivo flow study. Two experiments were performed
to study cell retention in vivo in rabbits; the first used shunt
tubing to connect grafts seeded with allogenic cells to the
aorta for 1 hour, and the second used grafts seeded with
autologous cells and implanted into the aorta for 1 day.
Three groups were defined: group 1 grafts were seeded
with EC only; group 2 grafts were seeded with SMC only;
group 3 grafts were seeded with EC on top of SMC.
For the flow study with shunts, a graft from each group
was sutured end-to-end with 6-0 prolene suture in a culture
plate containing medium. One centimeter of each 4-cm
graft from each group was cut before suturing as a preflow
control. Rabbits were anesthetized as described. They were
then shaved, and a No. 3 cuffed endotracheal tube was
inserted, after which the rabbits were placed on a heating
pad to maintain core body temperature. The left marginal
ear vein was cannulated for administration of intravenous
fluid: heparin, and pancuronium (0.05 mg/kg). The rab-
bits were placed on a ventilator and given 1% to 2% isoflu-
rane general anesthesia. The infrarenal aorta was mobilized
through a midline incision. After intravenous administra-
tion of heparin (400 IU per rabbit; Elkins-Sinn, Cherry
Hill, NJ), a 3-cm segment of aorta was isolated with bull-
dog clamps. The aorta was incised 2 cm longitudinally
between the clamps. The distal side of a Sundt external
carotid endarterectomy shunt tube (distal tubing, 1 mm
internal diameter (ID)  3 mm outer diameter (OD);
proximal tubing, 2 mm ID  4 mm OD; total length, 30
cm; NeuroCare Group, Pleasant Prairie, Wis) was inserted
into the opening proximally and secured with a circumaor-
tic silk suture. Similarly, a second Sundt shunt was inserted
distally. The three grafts previously sewn together in series
were connected between the two shunts. The order of the
three grafts from proximal to distal was either EC, SMC,
EC/SMC (four sets) or EC/SMC, SMC, EC (four sets).
The afferent limb was unclamped to let blood fill the graft
first, and then the clamp on the efferent limb was released
to open the blood circuit. Surgicel (Johnson & Johnson,
NJ) was used to cover the anastomoses externally for he-
mostasis. The abdomen was closed with clips (Fig 1, b). The
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procedure took approximately 40 minutes before starting
blood flow through the external circuit. After 1 hour of
blood flow, the first set of three grafts was replaced with a
second set of three grafts for another hour of blood flow.
Heparin (400 IU per rabbit) was administered again when
the grafts were switched.
After exposure to flow, the graft segments were re-
moved and the animals were euthanized with overdose
sodium pentabarbitol (125 mg/kg). Both preflow and
postflow grafts were rinsed with phosphate-buffered saline
solution (PBS) and fixed with 10% formaldehyle. The grafts
were stained with X-gal to visualize the seeded cells. The
number of residual cells was determined with a microscope
and expressed as cell density in cells per square millimeter.
For dual-layer seeded grafts, EC were quantitatively exam-
ined under bright field microscopy, and the SMC were
quantitatively examined with fluorescent microscopy.
Blood flow rate though the graft, aorta, and vein was
measured with a C-clamp type of ultrasonic flow probe
interfaced with a flow meter (Model T206; Transonic
Systems, Ithaca, NY). Shear stress in dynes per square
centimeter was calculated according to the formula 4Q/
r3, where  is the viscosity of the blood (0.04 g/cm/sec),
Q is flow rate in milliliters per second, and r is graft radius.21
During the experiment, rabbit systolic blood pressure mon-
itored in the ear ranged from 70 to 115 mm Hg, and
diastolic blood pressure varied from 55 mm to 95 mm Hg.
Blood pressure was maintained to achieve systolic blood
pressure of 90 to 100 mm Hg by giving bolus doses of
lactated Ringer solution with 5% dextrose. Blood pressure
measured within the PTFE graft with a needle was 10 mm
Hg higher than that measured with a cuff.
Long-term graft implantation. New Zealand white
rabbits were anesthetized and an endotracheal tube in-
serted as described. The infrarenal aorta was controlled
with a curved bulldog clamp, and a longitudinal aortotomy
was made with an 11-blade scalpel. The incision was
lengthened to 4 mm. A 5-cm-long, 4-mm-diameter PTFE
graft seeded with specified autologous cells was then sewn
in end-to-side with running 6-0 Prolene suture. Once the
proximal anastomosis was complete, the distal anastomosis
was similarly constructed just above the aortic bifurcation.
After graft placement, the aorta proximal to the distal
anastomosis was ligated, converting the anastomosis to a
functional end-to-end anastomosis. Aspirin (325 mg) was
given 5 hours after surgery only in rabbits undergoing
1-day implantation. Buprenorphine (0.05 mg/kg intra-
muscularly) was administered for postoperative analgesia at
12-hour intervals for 4 days. At graft harvest after 1-day,
30-day, or 100-day implantation, heparin (400 IU per
rabbit) was injected intravenously to prevent fresh clot
formation.
Neointimal measurement. The recovered grafts after
30-day or 100-day implantation were flushed with PBS and
cut into two parts: one part (a third of the graft) was opened
longitudinally for luminal analysis for thrombosis; the other
part (two thirds of the graft) was further cut into three
segments: proximal anastomosis (A), proximal third of
graft (P), and middle segment of graft (M). The segments
were embedded in ornithine carbamoyltransferase and fro-
zen in liquid nitrogen. Cut sections (4 m thick) were
mounted on glass slides and stained with hematoxylin-
eosin. The thickness of the neointima was measured with a
microscopic ruler at 8 evenly distributed locations on the
graft circumference. The average of the 8 values was used to
represent neointimal thickness in that graft segment. Thus
three sets of neointimal thickness measurements were made
in each rabbit, at positions A, P, and M. Because no
Fig 1. In vivo flow systems. a, In the shunt flow system, polytetrafluoroethylene (PTFE) grafts (inside diameter [ID],
4 mm) seeded with endothelial cells alone, smooth muscle cells alone, and endothelial cells on top of smooth muscle
cells were sutured together and connected to an afferent and efferent limb of external shunt tubings that were inserted
into rabbit aorta. b, Grafts were exposed to rabbit aorta blood flow for 1 hour. c, In the implanted system, individual
PTFE graft (ID, 4 mm; length, 5 cm) seeded with different cells was implanted end-to-side onto rabbit aorta, which was
ligated between the anastomosis. d, Grafts were recovered after 1, 30, and 100 days of implantation. Sections were
made at different positions (A, proximal anastomosis; P, proximal third of graft; M, middle of graft) to measure
neointima thickness.
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significant difference was observed in intimal thickness
based on positions A, P, or M, the data were averaged
across the three locations, yielding a final average of neoin-
timal thickness (Table I). There were 3 rabbits in each cell
seeding group.
Statistical analysis. Experimental values were ex-
pressed as mean  SD. Statistically significant differences
between groups were compared with the two-tailed Stu-
dent t test. P  .05 was considered statistically significant.
RESULTS
In vivo flow through shunts. Blood flow rate in the
aorta at the site of insertion was 50 mL/min, measured
before the shunts were inserted. Flow rate in the vena cava
was 48 mL/min. After insertion of the shunt tubing and
connection of the grafts (Fig 1), blood flow through the
graft was 35 mL/min. Blood pressure of 110/80 mm Hg
(systolic/diastolic with SD 10 mm Hg) was measured at
the onset of flow through the grafts. At the end of the
second set of graft implantations, blood pressure in the
grafts was 100/70 mm Hg. Shear stress is calculated as
3.72 dynes/cm2 at a mean flow rate of 35 mL/min within
the 4-mm-diameter PTFE graft.
After 1 hour in the circuit, SMC were better retained
than EC on the PTFE graft (Fig 2). EC retention rate was
65% 11% (n	 8) on grafts seeded with EC alone, which
was significantly (P .005) lower than SMC retention rate
of 95% 5% (n	 8) (Table II). EC seeded on top of SMC
had a significant better EC retention rate (98%  2%; P 
.005; n 	 8) than that of EC seeded alone (Fig 2).
The order of the three grafts sutured together did not
affect the results, ie, grafts linked in the order of EC, SMC,
EC/SMC (n 	 4) from proximal to distal demonstrated
similar results to those in grafts linked in the order of
EC/SMC, SMC, EC (n 	 4).
Cell retention after implantation. Cell retention
rates 1 day after implantation into rabbit aorta were similar
to those after 1-hour exposure (Table II). Retention rates
of SMC (89%  5%; n 	 7) or EC on top of SMC (90% 
4%; n 	 2) were significantly higher (P 	 .01) than those
seeded with EC only (51%  5%; n 	 2).
Intimal thickness after implantation. After individ-
ual grafts seeded with different combinations of EC and
SMC were implanted for 30 or 100 days (Fig 1, C), the
grafts were recovered (Fig 1, D) and neointimal thickness
was measured. No luminal thrombus was seen at either
time. The intimal thickness at the anastomosis was similar
to that at the middle of the graft (Table I). Mean neointi-
mal thickness on grafts seeded with EC was 52 45 m 30
days after implantation, and 79  48 m 100 days after
implantation. Neointimal thickness of the grafts seeded
with EC/SMC was 282 136 m and 126 60 m after
30-day and 100-day implantation, respectively. The neoin-
tima was significantly (P  .001; n 	 3) thicker on grafts
seeded with SMC and EC than on those seeded with only
EC 30 days after implantation. However, the neointima on
dual-cell seeded grafts was thinner 100 days after implan-
tation than 30 days after implantation. There was no sig-
nificant difference (P 	 .09; n 	 3) in intimal thickness
between grafts seeded with EC/SMC and those seeded
with EC 100 days after implantation. Total neointimal cell
density was independent of seeding strategy and duration
of implantation (2800-3400 cells/mm2).
DISCUSSION
Cell seeding to prevent graft thrombosis has been
investigated for more than two decades.1 Success has been
limited because of implantation trauma and shear stress. In
this report, we confirm in an in vivo rabbit model that EC
adhere poorly to PTFE grafts; nearly half the original
seeded cells were lost after overnight exposure to blood
flow.
To improve cell retention, SMC were used as a layer
intermediate between EC and PTFE graft. Unlike EC,
SMC adhere well to the deendothelialized arterial wall and
resist blood shear.22 Our model uses reporter genes to help
detect and differentiate cells. For dual-cell seeding experi-
ments, EC and SMC were transduced with retroviral vec-
tors carrying genes coding for 
-galactosidase and green
fluorescence protein, respectively, before seeding. After
G418 (neomycin analog) selection of the transduced cells,
all seeded cells carried the reporter gene. The expression of
the transduced gene was stable after nine passages in vitro
over 1 month,23 or 1 month after implantation in pig,20 or
7 months after implantation in dog (unpublished data). By
staining EC with X-gal and visualizing the graft surface
under fluorescent microscopy, SMC were readily differen-
tiated from EC. Cell retention was measured by counting
“blue-stained” cells (containing the lacZ gene) (Fig 2, D,
H). Since gene expression is stable both in vitro and in vivo,
Table I. Thickness (m) of neointimal layer on recovered PTFE grafts*
Cells seeded
Implantation period
30 Days 100 Days
A P M Average A P M Average
EC (m) 91  64 45  5 19  12 52  45 84  23 90  86 61  20 79  48
EC/SMC (m) 263  93 318  178 270  153 282  136 71  52 144  56 159  38 126  60
A, Proximal anastomosis; P, proximal third of graft; M, mid-graft.
*Circumference of each PTFE section was measured at eight evenly distributed points, which were then averaged to give the thickness per position per rabbit.
Average is mean of three different positions. Values represent average  SD from three rabbits for each group.
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and cell retention was assessed only after a short implanta-
tion time, using a marker gene to measure cell retention is
a reliable method.
This study confirms in vivo our previously reported in
vitro flow study results, which showed that EC seeded on
top of SMC resulted in better EC retention.15 SMC ad-
hered well to PTFE; 95% of SMC was retained after expo-
sure to blood flow for 1 hour. Cell attachment results from
the interaction between membrane proteins, eg, integrins,
and the underlying ECM.7 The difference between reten-
tion of EC and SMC could be caused by the amount of
ECM secreted by these cells. That SMC secrete a greater
amount of ECM could explain the increased cell attach-
ment. Adherent SMC improved EC retention when EC
were seeded on top of SMC. The EC retention rate was
98% when they resided on top of SMC, which is signifi-
cantly better than when EC were seeded alone (65%; P 
.005; n 	 8).
This rabbit aorta flow model provides a simple model
for studying the short-term effect of blood flow on seeded
cells. Several sets of grafts can be tested in 1 rabbit. We used
this flow system successfully for 5 hours to study the effect
of tPA expression from seeded cells on cell retention
(manuscript in preparation).
Unlike other reported in vivo studies of cell retention in
which autologous cells were used,14,16-18 allogenic cells
were used in our 1-hour shunt flow system and autologous
cells were used for implantation studies lasting 1 or more
days. We hypothesized that the host immunoglobin system
would not damage the seeded allogenic cells over the short
duration of these experiments. Schneider et al24 even used
heterogenic human EC seeded on PTFE grafts and exposed
to baboon blood flow for 1 hour to study the effect of EC
seeding in preventing platelet deposition. The use of allo-
genic cells enabled us to use one source of cells for all
rabbits. Although a host acute cellular immune response
may have had an effect on the allogenic seeded cells in the
short time of exposure, all three grafts were exposed to a
similar adverse immune environment.
Shunt flow system data were confirmed with the 1-day
flow data from implanted grafts in which the seeded cells
were isolated from each rabbit’s own jugular vein. EC
seeded alone lost nearly 50% of cells after being implanted
for 1 day, whereas only 10% of EC were lost when seeded
on top of SMC. Inasmuch as retention rates were not
reduced significantly between 1 hour of exposure and 1 day
after implantation, we speculate that the cell loss occurred
mainly at the beginning of exposure to the blood flow.
One concern with using SMC is the possibility of
increased neointimal thickness (neointimal hyperplasia)
caused by uncontrolled proliferation of seeded SMC. In
previous published studies, SMC have been used in endolu-
minal seeding procedures.10,22 The endoluminal seeded
SMC limited intimal hyperplasia both in a deendothelial-
ization model and in arterial allografts.22
The intimal layer was thicker on the EC/SMC seeded
grafts than on EC seeded grafts 30 days after implantation.
However, the neointimal thickness on EC or EC/SMC
seeded grafts 100 days after implantation was not signifi-
cantly different (P 	 .09; n 	 3). Because the variation is
large (SD 	 half of mean) and the animal number is small,
a type II statistical error could be present. More animal
experiments are needed to surely evaluate the effect of SMC
seeding on intimal hyperplasia. Data from separate experi-
ments show that the neointima is thicker on PTFE grafts
seeded with SMC alone than on grafts seeded with no cells
or seeded with EC/SMC 100 days after implantation
(manuscript in preparation). These data indicate that SMC
Fig 2. Cell retention on polytetrafluorethylene (PTFE) grafts after exposure to flow in vivo. PTFE grafts seeded with
endothelial cells (EC) alone (a, e), smooth muscle cells (SMC) alone (b, f), and EC on top of SMC (c, d, g, h) were
exposed to rabbit aortic blood flow for 1 hour. Recovered grafts were stained with X-gal. EC and SMC in single seeding,
which were transduced with lacZ gene, stained blue. SMC in double seeding can only be viewed under fluoromicros-
copy (d, h). Double seeding significantly improves surface retention of cells (g, h). (Original magnification, 110.)
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indeed will cause intimal hyperplasia and that EC seeding
above SMC may favorably modulate SMC proliferation.
EC markedly inhibit SMC growth in co-cultures of EC and
SMC.25,26 The endothelium is pivotal in modulating pro-
liferation and migration of SMC during vascular remodel-
ing. It has been well described that deendothelialization
during angioplasty causes accumulation of SMC in the
intima of arteries, leading to recurrent stenosis.27 Plasmin-
ogen activator inhibitor-1 secreted from the abluminal
surface of EC is one of the predominant effectors in con-
trolling SMC migration.28-30 This effect may be mediated
by decreased SMC matrix metalloproteinase activity.31
To prevent intimal hyperplasia induced by seeded
SMC, SMC can be modified in vitro by transducing them
with genes that modulate SMC proliferation, eg, nitric
oxide synthase (NOS)32 or homeobox transcription factor
Gax.33 We found that the neointima is thinner on grafts
seeded with SMC transduced with NOS gene than those
seeded with nontransduced SMC (unpublished data).
In addition to cell proliferation, extracellular matrix
secretion and deposition contribute significantly to neoin-
timal mass. We did not observe significant differences in
neointimal cell density among grafts seeded with different
cells. This finding suggests that the seeding strategy may
not influence ECM deposition.
Anastomotic intimal hyperplasia is a significant cause of
morbidity in patients with peripheral arterial prosthetic
bypass grafts.34,35 However, the anastomotic intimal thick-
ness (position A) was not significantly different from that at
other positions (position P and M) in this study (Table I).
We speculate that cells seeded on the graft may prevent
SMC migration from the adjacent artery.
We thank Dr Gary Striker for critical review of the
manuscript, and Stephanie Sengelman for data collection.
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